head and neck cancer
OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer
The French cancer center will use OncoDNA's blood-based next-generation sequencing test, OncoFollow, in its ongoing SCANDARE study.
Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay
The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow.
European Consortium Wins €6.9M Grant to Develop HPV16-Positive Cancer Vaccine
The consortium, led by a Belgium biotech, will use the funds to advance an mRNA-based vaccine as a treatment for head and neck, cervical, and anogenital cancers.
Abviris Raises Almost $2.4M to Expand Use of HPV-Related Cancer Test
The firm said it has developed a POC test that uses a biomarker for HPV16, which is responsible for more than 90 percent of all HPV-related head and neck tumors.
Bicara Therapeutics Launches With $40M Seed Funding, Bifunctional Antibody Pipeline
The company will explore the activity of its lead candidate, BCA101, in several molecularly defined cohorts in the dose-expansion portion of an ongoing Phase I/II trial.